Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Nursing | Pediatrics | Psychiatry | Rheumatology | Anesthesiology & Pain | Journal

Back to Journal Articles

Behavioral Therapy Effective in Juvenile Fibromyalgia

Last Updated: November 22, 2011.

 

Cognitive-behavioral therapy superior to fibromyalgia education for reducing disability

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Cognitive-behavioral therapy is superior to fibromyalgia education for reducing functional disability in adolescents with juvenile fibromyalgia, according to a study published online Nov. 22 in Arthritis & Rheumatism.

TUESDAY, Nov. 22 (HealthDay News) -- Cognitive-behavioral therapy (CBT) is superior to fibromyalgia education (FE) for reducing functional disability in adolescents with juvenile fibromyalgia (JFM), according to a study published online Nov. 22 in Arthritis & Rheumatism.

Sushmita Kashikar-Zuck, Ph.D., from the Cincinnati Children's Hospital Medical Center, and colleagues investigated the safety and efficacy of a CBT intervention compared with a FE program, for reducing functional disability, pain, and depressive symptoms in 114 adolescents (aged 11 to 18 years) with JFM. Following stabilization with usual medical care for eight weeks, patients were randomly allocated to receive eight-weekly CBT or FE sessions, and two booster sessions. Outcome measures were assessed at baseline, immediately after the eight-week treatment phase, and at a six-month follow-up.

The investigators found that 87.7 percent of participants completed the trial per protocol. In the intent-to-treat analyses, at the end of the study, patients from both groups had significantly reduced functional disability, pain, and depressive symptoms. However, CBT was significantly better than FE for reducing functional disability. Both groups had a clinically significant reduction in depressive symptoms, and by the end of the study, the mean scores were in the non-depressed range. Neither group attained a clinically significant reduction in pain (<30 percent reduction). No study-related adverse events occurred.

"In this controlled trial, CBT was found to be a safe and effective treatment for reducing functional disability and depressive symptoms in adolescents with JFM," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: Breast CA, Tenderness Linked in Women on Combo HRT Next: Adjuvant Capecitabine Does Not Improve Breast Cancer Survival

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.